Association of prevalent hypertension with 24-hour urinary excretion of calcium, citrate, and other factors
- PMID: 16632016
- DOI: 10.1053/j.ajkd.2006.01.024
Association of prevalent hypertension with 24-hour urinary excretion of calcium, citrate, and other factors
Abstract
Background: The relation between hypertension and the urinary excretion of calcium, citrate, and other factors is unclear. It has been proposed that increased urinary calcium excretion is a central feature of essential hypertension. Metabolic acidosis also may be associated with hypertension and decreases urinary citrate levels.
Methods: To compare the urine composition of individuals with and without hypertension, we studied 24-hour urinary excretion of calcium, citrate, oxalate, uric acid, sodium, magnesium, potassium, phosphorus, and creatinine and pH in a subset of participants with and without nephrolithiasis in the Nurses' Health Study I (older women; N = 1,284), Nurses' Health Study II (younger women; N = 952), and the Health Professionals Follow-up Study (men; N = 788). Logistic regression models adjusted for age, weight, dietary intake, and urinary factors.
Results: In participants with and without nephrolithiasis, citrate was the only urinary factor consistently related to hypertension. Compared with those in the lowest quartile of urinary citrate excretion, multivariate odds ratios of prevalent hypertension in the highest quartile were 0.37 (95% confidence interval [CI], 0.24 to 0.55; P trend < 0.001) for older women, 0.54 (95% CI, 0.32 to 0.92; P trend = 0.03) for younger women, and 0.27 (95% CI, 0.16 to 0.45; P trend < 0.001) for men. Urinary calcium levels were not related consistently to hypertension. Excluding participants with single 24-hour urine collections and those administered thiazide diuretics or angiotensin-converting enzyme inhibitors did not change the results.
Conclusion: Lower urinary citrate excretion is associated independently with prevalent hypertension. Factors that regulate urinary citrate excretion may play a role in hypertension.
Similar articles
-
Body size and 24-hour urine composition.Am J Kidney Dis. 2006 Dec;48(6):905-15. doi: 10.1053/j.ajkd.2006.09.004. Am J Kidney Dis. 2006. PMID: 17162145
-
Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.J Urol. 2009 Mar;181(3):1140-4. doi: 10.1016/j.juro.2008.11.020. Epub 2009 Jan 18. J Urol. 2009. PMID: 19152919
-
Hypertension is associated with increased urinary calcium excretion in patients with nephrolithiasis.J Urol. 2010 Feb;183(2):576-9. doi: 10.1016/j.juro.2009.10.011. Epub 2009 Dec 16. J Urol. 2010. PMID: 20018328
-
Unravelling the links between calcium excretion, salt intake, hypertension, kidney stones and bone metabolism.J Nephrol. 2000 May-Jun;13(3):169-77. J Nephrol. 2000. PMID: 10928292 Review.
-
Hypertension, calcium metabolism, and nephrolithiasis.Am J Med Sci. 1994 Feb;307 Suppl 1:S102-6. Am J Med Sci. 1994. PMID: 8141146 Review.
Cited by
-
Determinants of calcium and oxalate excretion in subjects with calcium nephrolithiasis: the role of metabolic syndrome traits.J Nephrol. 2018 Jun;31(3):395-403. doi: 10.1007/s40620-017-0453-3. Epub 2017 Oct 31. J Nephrol. 2018. PMID: 29090382
-
Relationship between urine specific gravity and the prevalence rate of kidney stone.Transl Androl Urol. 2021 Jan;10(1):184-194. doi: 10.21037/tau-20-929. Transl Androl Urol. 2021. PMID: 33532308 Free PMC article.
-
Is oxidative stress, a link between nephrolithiasis and obesity, hypertension, diabetes, chronic kidney disease, metabolic syndrome?Urol Res. 2012 Apr;40(2):95-112. doi: 10.1007/s00240-011-0448-9. Epub 2012 Jan 4. Urol Res. 2012. PMID: 22213019 Free PMC article. Review.
-
Is the METS-IR Index a Potential New Biomarker for Kidney Stone Development?Front Endocrinol (Lausanne). 2022 Jul 14;13:914812. doi: 10.3389/fendo.2022.914812. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35909543 Free PMC article.
-
Nephrolithiasis and hypertension: possible links and clinical implications.J Nephrol. 2014 Oct;27(5):477-82. doi: 10.1007/s40620-014-0068-x. Epub 2014 Feb 28. J Nephrol. 2014. PMID: 24577680 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases